Is Now The Time To Look At Buying CloudMD Software & Services Inc. (CVE:DOC)?

CloudMD Software & Services Inc. (CVE:DOC), might not be a large cap stock, but it saw a significant share price rise of over 20% in the past couple of months on the TSXV. As a stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. But what if there is still an opportunity to buy? Let’s take a look at CloudMD Software & Services’s outlook and value based on the most recent financial data to see if the opportunity still exists.

Check out our latest analysis for CloudMD Software & Services

What Is CloudMD Software & Services Worth?

Good news, investors! CloudMD Software & Services is still a bargain right now. According to my valuation, the intrinsic value for the stock is CA$0.67, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. However, given that CloudMD Software & Services’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility.

Can we expect growth from CloudMD Software & Services?

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With profit expected to grow by 46% over the next year, the near-term future seems bright for CloudMD Software & Services. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

What This Means For You

Are you a shareholder? Since DOC is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With an optimistic outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current undervaluation.

Are you a potential investor? If you’ve been keeping an eye on DOC for a while, now might be the time to enter the stock. Its buoyant future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy DOC. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed investment decision.

If you want to dive deeper into CloudMD Software & Services, you'd also look into what risks it is currently facing. Case in point: We've spotted 2 warning signs for CloudMD Software & Services you should be aware of.

If you are no longer interested in CloudMD Software & Services, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.